|
COPYRIGHT 2006 International Medical News Group
Adding ezetimibe to simvastatin was found to be safe in a pilot study of patients with chronic kidney disease, and the combined regimen decreased LDL cholesterol by approximately 40%, according to Martin Landray, Ph.D., of the University of Oxford (England) and his associates.
The 6-month study involved 203 patients treated for chronic kidney...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
